Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – What’s Next?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped up before the market opened on Tuesday. The stock had previously closed at $6.60, but opened at $6.95. Coloplast A/S shares last traded at $6.88, with a volume of 3,927 shares changing hands.

Coloplast A/S Stock Performance

The firm’s fifty day simple moving average is $6.72 and its 200 day simple moving average is $6.45. The company has a market capitalization of $15.46 billion, a price-to-earnings ratio of 36.12, a PEG ratio of 2.35 and a beta of 0.21. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.11 billion. On average, sell-side analysts forecast that Coloplast A/S Sponsored ADR will post 0.40 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.